BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is closely associated
with insulin resistance and metabolic syndrome. Prevalence of NAFLD increases greatly in …

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of liver disease from simple
steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is commonly …

Background & Aims The increasing rates of obesity and type 2 diabetes mellitus may lead to
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …

Abstract Background & Aims The aim of this study was to evaluate the impact of non‐
alcoholic fatty liver disease (NAFLD) on incident type 2 diabetes mellitus (T2 DM) in non …

Context and Objective: Nonalcoholic fatty liver disease (NAFLD) and its more severe form
with steatohepatitis (NASH) are common in patients with type 2 diabetes mellitus (T2DM) …

Background Nonalcoholic fatty liver disease (NAFLD) has been linked to an increased risk
of cardiovascular disease (CVD). To explore the impact of diabetes mellitus (DM) as a …

Non-alcoholic fatty liver disease (NAFLD) produces high morbidity and mortality rates. Its
worldwide prevalence is 25%, but evidence from Latin America (LA) is lacking. We aimed to …

Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-
associated steatotic liver disease (MASLD) affects~ 70% of patients with type 2 diabetes …

Background While non-alcoholic fatty liver disease (NAFLD) has been well characterised in
patients with diabetes mellitus (DM), less is known about NAFLD in non-DM patients. We …

Objective Non-alcoholic fatty liver disease (NAFLD) is a major public health burden in
China, and its prevalence is increasing. This study aimed to determine the risk factors and …